Corporate

Contract Research Organisations (CROs) are often associated with the operational side of clinical trials: patient recruitment, data management, site monitoring

We are pleased to share that the first patient has now been dosed in a Phase 2 clinical trial –

If you’re a researcher with a promising therapeutic, device or intervention, there comes a point where someone suggests taking it

MAC Clinical Research is pleased to announce the successful dosing of the first participant in a Phase 2 clinical study

MAC Clinical Research and Kariya Pharmaceuticals are pleased to share the successful dosing of the first cohort in the Phase

MAC Clinical Research (MAC) announces regulatory approval to initiate a PII clinical trial for mavatrep, an investigational, oral, TRPV1-receptor (transient

April is Stress Awareness Month and a perfect opportunity to reflect on the stress in our lives and how we

Taking a new treatment from lab to patient is a long, highly regulated process that demands years of research, significant

MAC Clinical Research is delighted to announce that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved amendments

Effective project management is vital to the success of a clinical trial, helping to ensure that studies are conducted smoothly,